Financial Counselors Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-47,604
Closed -$39.3M 318
2025
Q1
$39.3M Sell
47,604
-2,995
-6% -$2.49M 0.6% 49
2024
Q4
$39.1M Buy
50,599
+1,806
+4% +$1.5M 0.57% 48
2024
Q3
$43.2M Sell
48,793
-2,755
-5% -$2.48M 0.64% 44
2024
Q2
$46.7M Sell
51,548
-1,498
-3% -$1.2M 0.75% 38
2024
Q1
$41.3M Buy
53,046
+1,124
+2% +$800K 0.7% 42
2023
Q4
$30.3M Buy
51,922
+4,003
+8% +$2.34M 0.54% 54
2023
Q3
$25.7M Sell
47,919
-5,003
-9% -$2.58M 0.51% 59
2023
Q2
$24.8M Sell
52,922
-1,294
-2% -$543K 0.5% 58
2023
Q1
$18.6M Sell
54,216
-552
-1% -$186K 0.4% 73
2022
Q4
$20M Sell
54,768
-1,527
-3% -$541K 0.45% 64
2022
Q3
$18.2M Buy
56,295
+81
+0.1% +$25.7K 0.45% 66
2022
Q2
$18.2M Buy
56,214
+1,869
+3% +$561K 0.43% 72
2022
Q1
$15.6M Buy
54,345
+257
+0.5% +$66.1K 0.32% 92
2021
Q4
$14.9M Sell
54,088
-864
-2% -$219K 0.31% 93
2021
Q3
$12.7M Buy
54,952
+282
+0.5% +$69.6K 0.27% 108
2021
Q2
$12.5M Sell
54,670
-694
-1% -$139K 0.27% 107
2021
Q1
$10.3M Buy
55,364
+2,401
+5% +$470K 0.24% 121
2020
Q4
$8.94M Buy
52,963
+31
+0.1% +$4.63K 0.22% 119
2020
Q3
$7.83M Sell
52,932
-835
-2% -$129K 0.23% 114
2020
Q2
$8.83M Sell
53,767
-12,808
-19% -$1.97M 0.28% 100
2020
Q1
$9.23M Sell
66,575
-404
-0.6% -$55.5K 0.41% 82
2019
Q4
$8.8M Buy
66,979
+1,301
+2% +$151K 0.31% 103
2019
Q3
$7.34M Sell
65,678
-14
-0% -$1.56K 0.29% 115
2019
Q2
$7.28M Buy
65,692
+247
+0.4% +$29.1K 0.3% 115
2019
Q1
$8.49M Sell
65,445
-22,852
-26% -$2.78M 0.36% 91
2018
Q4
$10.2M Sell
88,297
-1,448
-2% -$162K 0.5% 62
2018
Q3
$9.63M Sell
89,745
-2,135
-2% -$213K 0.42% 81
2018
Q2
$7.84M Sell
91,880
-1,497
-2% -$123K 0.36% 94
2018
Q1
$7.22M Buy
93,377
+2,331
+3% +$188K 0.34% 101
2017
Q4
$7.69M Sell
91,046
-684
-0.7% -$58.2K 0.35% 95
2017
Q3
$7.85M Sell
91,730
-778
-0.8% -$63.8K 0.38% 85
2017
Q2
$7.61M Buy
92,508
+350
+0.4% +$28.6K 0.38% 92
2017
Q1
$7.75M Buy
92,158
+2,230
+2% +$179K 0.4% 84
2016
Q4
$6.61M Buy
+89,928
New +$6.7M 0.35% 97
2016
Q2
$5.43M Buy
69,008
+12,690
+23% +$955K 0.32% 110
2016
Q1
$4.05M Buy
56,318
+451
+0.8% +$34.1K 0.25% 139
2015
Q4
$4.71M Sell
55,867
-467
-0.8% -$38.8K 0.3% 114
2015
Q3
$4.71M Sell
56,334
-6,270
-10% -$529K 0.32% 107
2015
Q2
$5.23M Sell
62,604
-421
-0.7% -$32.1K 0.33% 104
2015
Q1
$4.58M Sell
63,025
-5,875
-9% -$418K 0.28% 125
2014
Q4
$4.75M Buy
68,900
+632
+0.9% +$42.7K 0.3% 111
2014
Q3
$4.43M Buy
68,268
+2,802
+4% +$177K 0.31% 106
2014
Q2
$4.07M Sell
65,466
-2,010
-3% -$120K 0.28% 114
2014
Q1
$3.97M Buy
67,476
+1,763
+3% +$98.4K 0.29% 117
2013
Q4
$3.35M Buy
65,713
+1,686
+3% +$84.4K 0.25% 129
2013
Q3
$3.22M Sell
64,027
-3,918
-6% -$205K 0.27% 124
2013
Q2
$3.34M Buy
+67,945
New +$3.7M 0.28% 117

Other funds holding LLY

Financial Counselors Inc's LLY Position: Q2 2025 in Review

Financial Counselors Inc sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 47,604 shares — an estimated $39.3M sold.

Financial Counselors Inc first reported a position in LLY in Q2 2013 and held it in 47 quarters. The position peaked at $46.7M in Q2 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Financial Counselors Inc reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Financial Counselors Inc sold 47,604 Eli Lilly shares in Q2 2025, an estimated $39.3M.
  • Financial Counselors Inc first reported a position in Eli Lilly in Q2 2013 and held it in 47 quarters.
  • Financial Counselors Inc's Eli Lilly position peaked at $46.7M in Q2 2024.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Financial Counselors Inc's 13F filing for Q2 2025, filed 1 Aug 2025.